Johnson & Johnson's Fourth-Quarter Results Leave Wall Street With Mixed Emotions
Johnson & Johnson (NYSE: JNJ) kicked off another earnings season with fourth-quarter results that missed analysts' consensus estimates on the top line, but contained enough positive surprises to keep the stock from plunging.
The world's largest healthcare company reported revenue of $20.75 billion, which was $80 million less than the average Wall Street estimate. The bottom line was a different story: Adjusted earnings of $1.88 per share surpassed expectations by one penny.
Image source: Getty Images.
Source Fool.com
